Wang, Xiaoqian http://orcid.org/0009-0006-3288-544X
Wang, Wenying
Li, Jingjing
An, Ruifang
Chen, Lihong
Lin, Jiajing
Xu, Dabao
Qiu, Jin
Song, Weihua
Patiman, Mijiti
Ruan, Hongjie
Wang, Gang
Xue, Fengxia
Wang, Xu
Luo, Xiaowan
Ruan, Qi
Shi, Ling
Zhang, Chun
Hu, Lina
Wang, Shijin
Shi, Hong
Wang, Xiaoli
Zhang, Songling
Li, Yingxiong
Lu, Jing
Wang, Baojin
Xu, Hongyan
Ye, Hong
Zhang, Bei
Zhang, Chunlian
Qian, Sumin
Wu, Qiong
Jia, Wen
Li, Chuan
Liao, Qinping http://orcid.org/0000-0001-9175-1560
Funding for this research was provided by:
Jiangsu Hansoh Pharmaceutical Group Co. Ltd
Article History
Received: 25 January 2024
Accepted: 11 March 2024
First Online: 3 April 2024
Declarations
:
: Qiong Wu, Wen Jia and Chuan Li are the employees of Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Other authors have nothing to disclose.
: All procedures performed in studies involving human participants were in accordance with the Declaration of Helsinki, Good Clinical Practice, and the current International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use Guidelines. The study was also approved by the ethics committees of the study sites.
: Informed consent was obtained from all individual participants included in the study.